---
title: "GENOME THERAPEUTICS LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/89202590-ecb0-5292-91e4-bca4ffae6bc2
json: https://whiteintel.dev/api/public/dossier/89202590-ecb0-5292-91e4-bca4ffae6bc2
identifier: oo:GB-COH-12392992
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GENOME THERAPEUTICS LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-12392992`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/89202590-ecb0-5292-91e4-bca4ffae6bc2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/89202590-ecb0-5292-91e4-bca4ffae6bc2  

## Ownership & control

### Owners / controllers

- **Dr Samuel Aparicio** (beneficial owner) — 50% — https://whiteintel.dev/entity/dd6d45fc-f7e4-53be-8cf6-f3677365732b
- **Dr Samuel Aparicio** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/2f52e5dd-2bf1-49be-b2d6-206e37af8f59
- **Dr Samuel Aparicio** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/52c9c39c-eaf7-479e-b671-2148ec95fbf3
- **Prof Sir Shankar Balasubramanian** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/32b175e6-4a23-48c4-b5d0-71027abc7ee7
- **Dr Bobby Satyadev Yerramilli-Rao** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/01bf0ef3-9df4-4ac6-8da9-6718d019bfbf

### UBO chain (walk to the ultimate owner)

A **5-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `12392992`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2020-01-08
- **Registered office:** Regent House, 316 Beulah Hill, London, SE19 3HF, United Kingdom
- **SIC:** 72110

### Officers

- APARICIO, Samuel, Dr — director · Canadian · appointed 2025-09-14
- GLASHEEN, James Walter, Dr — director · American · appointed 2025-10-20
- KLEIN, Saul Charles — director · British · appointed 2025-08-08
- MCHUGH, Dan — director · American,Irish · appointed 2022-04-28
- YERRAMILLI-RAO, Bobby Satyadev, Dr — director · British · appointed 2024-06-06
- [MBM SECRETARIAL SERVICES LIMITED](https://whiteintel.dev/entity/8d652179-e4de-52fd-815e-c141166d9128) — corporate secretary · appointed 2020-01-08 · resigned 2025-01-07
- APARICIO, Samuel, Dr — director · Canadian · appointed 2022-04-28 · resigned 2024-06-06
- BALASUBRAMANIAN, Shankar, Prof Sir — director · British,Indian · appointed 2020-01-08 · resigned 2025-09-14
- MAHMOOD, Saiyed Ibraheem — director · British · appointed 2024-06-06 · resigned 2024-12-02

### Beneficial owners (Persons with Significant Control)

- Dr Samuel Aparicio — 25–50% shares · individual PSC · United Kingdom — ceased 2025-08-08
- Dr Samuel Aparicio — 25–50% shares · individual PSC · United Kingdom — ceased 2024-10-18
- Prof Sir Shankar Balasubramanian — 25–50% shares · individual PSC · United Kingdom — ceased 2025-08-08
- Dr Bobby Satyadev Yerramilli-Rao — 25–50% shares · individual PSC · United Kingdom — ceased 2020-01-29

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/12392992
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/12392992

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GENOME THERAPEUTICS LTD**. Human view: https://whiteintel.dev/entity/89202590-ecb0-5292-91e4-bca4ffae6bc2 · Structured JSON: https://whiteintel.dev/api/public/dossier/89202590-ecb0-5292-91e4-bca4ffae6bc2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._